Structural plasticity in the oestrogen receptor ligand-binding domain
about
3D models of MBP, a biologically active metabolite of bisphenol A, in human estrogen receptor α and estrogen receptor βIdentification of xenoestrogens in food additives by an integrated in silico and in vitro approachDoubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by DeacylcortivazolNFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analysesThe Structural Basis of Gas-Responsive Transcription by the Human Nuclear Hormone Receptor REV-ERBβCoupling of receptor conformation and ligand orientation determine graded activityStructure of Estradiol Metal Chelate and Estrogen Receptor Complex: The Basis for Designing a New Class of Selective Estrogen Receptor ModulatorsLigand-binding dynamics rewire cellular signaling via estrogen receptor-αDeciphering Modern Glucocorticoid Cross-pharmacology Using Ancestral Corticosteroid ReceptorsDevelopment of Selective Estrogen Receptor Modulator (SERM)-Like Activity Through an Indirect Mechanism of Estrogen Receptor Antagonism: Defining the Binding Mode of 7-Oxabicyclo[2.2.1]hept-5-ene Scaffold Core LigandsStructural overview of the nuclear receptor superfamily: insights into physiology and therapeutics.Screening Chemicals for Receptor-Mediated Toxicological and Pharmacological Endpoints: Using Public Data to Build Screening Tools within a KNIME Workflow.Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status.Dual RXR Agonists and RAR Antagonists Based on the Stilbene Retinoid Scaffold.Potential activity of fevicordin-A from Phaleria macrocarpa (Scheff) Boerl. seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies.Synthesis and functional analysis of novel bivalent estrogens.Probing the topological tolerance of multimeric protein interactions: evaluation of an estrogen/synthetic ligand for FK506 binding protein conjugate.Versatility or promiscuity: the estrogen receptors, control of ligand selectivity and an update on subtype selective ligands.Structural and functional insights into nuclear receptor signaling.Histone deacetylase inhibitors equipped with estrogen receptor modulation activity.Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.Behavior of solvent-exposed hydrophobic groove in the anti-apoptotic Bcl-XL protein: clues for its ability to bind diverse BH3 ligands from MD simulations.Virtual screening of the estrogen receptor.Structural and functional profiling of environmental ligands for estrogen receptors.Multiple-targeting and conformational selection in the estrogen receptor: computation and experiment.The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligandsSteroidal bivalent ligands for the estrogen receptor: design, synthesis, characterization and binding affinities.Structural and functional analysis of domains of the progesterone receptor.Synthesis and evaluation of 17α-E-20-(heteroaryl)norpregn-1,3,5(10),20 tetraene-3,17β-diols [17α-(heteroaryl)vinyl estradiols] as ligands for the estrogen receptor-α ligand binding domain (ERα-LBD).Targeting the estrogen receptor with metal-carbonyl derivatives of estradiolIdentification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide.Synthesis and evaluation of 17α-(dimethylphenyl)vinyl estradiols as probes of the estrogen receptor-α ligand binding domain.Synergistic activation of human pregnane X receptor by binary cocktails of pharmaceutical and environmental compounds.Tetradian oscillation of estrogen receptor α is necessary to prevent liver lipid deposition.Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and AntagonistsOrigin of an ancient hormone/receptor couple revealed by resurrection of an ancestral estrogenSelective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast CancerNeural-Network Scoring Functions Identify Structurally Novel Estrogen-Receptor Ligands.The natural estrogenic compound diarylheptanoid (D3): in vitro mechanisms of action and in vivo uterine responses via estrogen receptor αNonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor.
P2860
Q21560757-C80234B2-26AC-4874-BF44-79F4AA4C8DB4Q24656051-64F3937F-9C75-411D-BBDA-ED9F5DA05B53Q27649439-545351D4-579A-4790-87F3-93113D6B0650Q27650089-7F55D04D-B2EF-4D60-B5A7-EEE9D0B5F694Q27653944-C742B3A0-B09F-40B3-BBA4-7A2CAEA9C2AEQ27664921-EBF85536-F43C-43C9-8703-DA89F84F987AQ27667460-B8F93963-B63F-47D5-894C-668821047A9BQ27677013-9EC116CA-6DDC-4F2D-A42D-69983B526849Q27678139-DE517EF0-DD10-49CE-8754-7E50E6365352Q27678627-9C85898D-398B-4C5E-AFCD-E814B40D4E2BQ30418832-84DF48C7-B8B9-41AC-B47C-3222D500072FQ30489654-7B80CF3D-9D32-450D-83C0-09BC3563B641Q31097623-A46F47B6-CA51-4F47-97B8-6D6509C4F452Q33636514-E036B634-25E1-4221-9D81-8E013881FABBQ33755530-E4E2A9B2-A699-4397-9B6B-A026B4DE2245Q34170273-44F44157-F797-4F2F-8806-2B8C9577747EQ34257756-D7380FE4-3490-4D6C-9F3F-95EEDF65B66FQ34347992-DCBCCF53-95E9-4090-ADB7-1297478E0688Q34348135-90BEC3C0-37DC-41B5-B736-AA96E9F64F25Q34352264-8E96A3A3-7F83-4999-AF2F-2C9BCB2FD796Q34607003-8678CCB0-C8C8-41DB-9E58-3F4C846335B0Q34611338-417706C7-55BB-45D0-8D7F-DE8F4E9D6C70Q34619281-4318D4A2-E2D9-4AB0-8F96-54A2CD4E82A0Q34632938-0600062E-AA3F-425E-9A9A-65756F96D7CCQ35046420-5179D613-D750-428E-A021-9714E580D918Q35148605-787636B0-8577-4E67-B888-3CB65B6A819FQ35227529-F8C2BAF1-A942-4287-8755-372A4D702B71Q35624126-72A5BB1E-B76B-44E5-B491-DFBB3D50795BQ35676299-A74CF771-EDBE-438D-9FCD-C27341A50D8DQ35742807-7653B8A3-99C8-4156-BD1C-51990ADBF964Q35815534-0D800151-A57B-4F9F-ABCA-D89BC47635FEQ35839439-88588A47-B50A-4868-9A12-A3743560B864Q36059350-414A9261-7674-499B-ABFB-EE55CD7769F4Q36122649-F981FB7D-B439-4244-AAE3-8D1F9E944C34Q36243027-9DF7BDAE-90A5-4A78-9085-1BA59671EE84Q36354712-CD8DC71F-7EFE-44C8-8C3B-DB5D308F112EQ36656704-624F38E5-CFC2-4F59-9613-AD90A870D6B1Q36658263-5D72BC89-C56C-43CE-9BB4-C6F9EAEC9621Q36750997-49E2793D-0C4A-4834-AAEC-00D442F01299Q36781304-321D4907-9D48-4A29-A9D7-83A5308D2B54
P2860
Structural plasticity in the oestrogen receptor ligand-binding domain
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Structural plasticity in the oestrogen receptor ligand-binding domain
@ast
Structural plasticity in the oestrogen receptor ligand-binding domain
@en
Structural plasticity in the oestrogen receptor ligand-binding domain
@nl
type
label
Structural plasticity in the oestrogen receptor ligand-binding domain
@ast
Structural plasticity in the oestrogen receptor ligand-binding domain
@en
Structural plasticity in the oestrogen receptor ligand-binding domain
@nl
prefLabel
Structural plasticity in the oestrogen receptor ligand-binding domain
@ast
Structural plasticity in the oestrogen receptor ligand-binding domain
@en
Structural plasticity in the oestrogen receptor ligand-binding domain
@nl
P2093
P2860
P3181
P356
P1433
P1476
Structural plasticity in the oestrogen receptor ligand-binding domain
@en
P2093
Alun Hughs
Erin E O'Neill
Eugene R DeSombre
Geoffrey L Greene
Jason Nowak
John B Bruning
Kendall W Nettles
Robert Dilis
Robert N Hanson
Younchang Kim
P2860
P3181
P356
10.1038/SJ.EMBOR.7400963
P577
2007-06-01T00:00:00Z